Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Su Jin Jang
Institutions:
CHA University Bundang Medical Center,
CHA University
Observed institutions:
CHA University Bundang Medical Center,
CHA University
ORCID:
0000-0001-6103-6830
Observed ORCID:
0000-0001-6103-6830
OpenAlex ID:
A5121346813
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC : An International Multicentre Study
2025
·
Jung Sun Kim
, Jeffrey Wong
, et al.
·
Liver International
·
11
PDF
Efficacy of Nivolumab plus Ipilimumab in Advanced Hepatocellular Carcinoma with and without High-Risk Features: An International Multicenter Study
2026
·
Jung Sun Kim
, San-Chi Chen
, et al.
·
Liver Cancer
·
1
PDF
Prognostic Value of FDG PET/CT Parameters in Patients With Advanced Biliary Tract Cancer Receiving Gemcitabine, Cisplatin, and Nab-Paclitaxel
2026
·
Jeong Won Lee
, Sang Mi Lee
, et al.
·
Clinical Nuclear Medicine
Show more works
View as search
Works count:
3
Citation count:
12
H-index:
1
I10-index:
1
Year
Topic
Type